NOCODEBIOASSAYPHARMACOLOGICAL RELEVENCETURN AROUND TIME
1.         BCA01a - Amylase inhibition Obesity, Type II Diabetes, Carbohydrate blocker2 weeks
2.         BCA02a - Glucosidase inhibition Type II Diabetes, Carbohydrate blocker2 weeks
3.         BCA03b - Glucuronidase inhibition Hepatoprotection, Axillary odour, 2 weeks
4.         BCA04ABTS radical scavenging Anti-oxidant2 weeks
5.         BCA05Acetylcholinesterase inhibition*Cognition enhancement, Neuro- degenerative disorders2 weeks
6.         BCA06Aryl Sulphatase inhibitionAxillary odour2 weeks
7.         BCA07Butyrylcholinesterase inhibition*Cognition enhancement, Neuro- degenerative disorders2 weeks
8.         BCA08Collagenase inhibition Ageing / Wrinkle3 weeks
9.         BCA09Nitric-oxide scavenging Anti-oxidant, Alzheimer’s disease2 weeks
10.     BCA10Superoxide anion scavenging (PMS-NADH system)Anti-oxidant2 weeks
11.     BCA11DPP IV inhibition Type II Diabetes, Obesity3 weeks
12.     BCA12DPPH* radical scavengingAnti-oxidant2 weeks
13.     BCA13Elastase inhibition Wrinkle, Ageing2 weeks
14.     BCA14Hyaluronidase inhibition Inflammation, Allergy2 weeks
15.     BCA15Hydroxyl radical scavenging Anti-oxidant2 weeks
16.     BCA16Lipase inhibition Obesity3 weeks
17.     BCA1715 - Lipoxygenase inhibition Inflammation3 weeks
18.     BCA18Trypsin inhibition Inflammation2 weeks
19.     BCA19Xanthine oxidase inhibition Gout2 weeks
20.     BCA20TC- PTPase inhibition Selectivity testing assay for anti-phosphatase activity3 weeks
21.     BCA21PTP-IB inhibition Type II Diabetes, Obesity3 weeks
22.     BCA22Aldolase inhibition Carbohydrate blocker2 weeks
23.     BCA23COX-I inhibition Done along COX II assay to know selectivity5 weeks
24.     BCA24COX II inhibition Inflammation, Pain5 weeks
25.     BCA25Phosphodiesterase –I inhibition Arthritis2 weeks
26.     BCA26Protein phosphatase-1 inhibition Cognition enhancement, Neuro- degenerative disorders2 weeks
27.     BCA28Thymidine phosphorylase (TP) inhibition Psoriasis2 weeks
28.     BCA29Rho-kinase (ROCK-II) inhibition Erectile dysfunction, Type II Diabetes3 weeks
29.     BCA31Angiotensin converting enzyme (ACE) inhibition Hypertension6-8 weeks
30.     BCA32Tyrosinase inhibition Skin whitening3 weeks
31.     BCA33PARP inhibitionNeuro degenerative disorders, Diabetic nephropathy3 weeks
32.     BCA34PLA2 inhibition Inflammation3 weeks
33.     BCA35PAF acetylhydrolase inhibitionAtherosclerosis3 weeks
34.     BCA36IKK-ß (NF-B kinase) inhibition Type II Diabetes, Inflammation4 weeks
35.     BCA37Glucose-6-Phosphatase inhibition Type II Diabetes4 weeks
36.     BCA38P70S6kinase inhibition Type II Diabetes4 weeks
37.     BCA39ORAC (hydrophilic)Anti-oxidant3 weeks
38.     BCA40SIRT-1 activationType II Diabetes, Obesity, Ageing4 weeks
39.     BCA41Cholesterolesterase inhibition Hypercholestrolemia / atherosclerosis4 weeks
40.     BCA42MGL inhibition Pain, Neuro-degenerative disorders4 weeks
41.     BCA43ORAC (lipophilic)Anti-oxidant4 weeks
42.     BCA45Advanced Glycated Endproducts inhibition (AGE)Diabetic complications3 weeks
43.     BCA4720S ProteosomeType II Diabetes4 weeks
44.     BCA48Aldose reductase Diabetic retinopathy6 weeks
45.     BCA4911-beta-HSD1Type II Diabetes4 weeks
46.     BCA50mTOR inhibition Type II Diabetes4 weeks
47.     BCA51HORACAnti-oxidant2 weeks
48.     BCA52Prolyl Endo-Peptidase (PEP) inhibitionCognition enhancement2 weeks
49.     BCA53Monoacyl Glycerol AcylTransferase-2 (MGAT-2)Cholesterol lowering4 weeks
50.     BCA54Monoamineoxidase B inhibitionAnti-depressant4 weeks
51.     BCA55Insulin Regulated Amino Peptidase inhibition (IRAP)Cognition enhancement4 weeks
52.     BCA56NORAC assay Anti-oxidant4 weeks
53.     BCA57COMT assay NEWCognition enhancement3 weeks
54.     BCA58FRAP assay NEWAnti-oxidant3 weeks